BioWorld

Jan. 19, 2009

View Archived Issues

Stock Winners and Losers For The Week

Phase I Clinical Trials Update: December 2008

Phase II Clinical Trials Update: December 2008

Pivotal/Phase III Clinical Trials Update: December 2008

American Society of Hematology's 50th Annual Meeting: December 2008

Non-U.S. Clinical Trials And Regulatory Actions: December 2008

FDA Submissions, Approvals And Other Actions: December 2008

Will Health Care Reform Save Biotech, Economy?

Making health care more affordable, accessible, effective and safe, but less costly, for Americans has been an ongoing debate for decades, with little achieved over the many years of discussion. (BioWorld Financial Watch) Read More

Money Raised Year to Date

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for June 5, 2026.

New York University identifies new analogues of mannose-6-phosphate

BioWorld Science

New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...

ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins

BioWorld

If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...

Bial-Portela discovers new OX1 receptor antagonists

BioWorld Science

Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...

FB-7033 demonstrates efficacy in MASH management

BioWorld Science

17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...